| OAZIX | TBCUX | OAZIX / TBCUX | |
| Total Expense Ratio | 0.75 | 1.42 | 53% |
| Annual Report Gross Expense Ratio | 0.75 | 1.43 | 52% |
| Fund Existence | 5 years | 16 years | - |
| Gain YTD | 23.536 | 21.454 | 110% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 2500 | 40,000% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 14.4B | 181M | 7,956% |
| Annual Yield % from dividends | 2.23 | 1.87 | 119% |
| Returns for 1 year | 24.29 | 2.35 | 1,035% |
| Returns for 3 years | 38.01 | 18.51 | 205% |
| Returns for 5 years | N/A | 23.36 | - |
| Returns for 10 years | N/A | 45.90 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BXMX | 14.12 | 0.08 | +0.57% |
| NUVEEN S&P BUY-WRITE Income FUND | |||
| INFO | 23.82 | 0.06 | +0.23% |
| Harbor PanAgora Dynamic Lg Cp Cor ETF | |||
| IQHI | 26.12 | N/A | N/A |
| NYLI MacKay High Income ETF | |||
| CAPE | 31.47 | -0.20 | -0.62% |
| DoubleLine Shiller CAPE US Equities ETF | |||
| IBRN | 29.58 | -0.24 | -0.82% |
| iShares Neuroscience and Healthcare ETF | |||